{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:33:18Z","timestamp":1791343998196,"version":"4.3.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:00:00Z","timestamp":1450396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/leu.2015.348","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T07:43:32Z","timestamp":1450424612000},"page":"914-918","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value"],"prefix":"10.1038","volume":"30","author":[{"given":"A","family":"Pardanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K K","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Zblewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E A","family":"Wassie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W G","family":"Morice II","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Grogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C A","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"BFleu2015348_CR1","doi-asserted-by":"publisher","first-page":"25999","DOI":"10.1074\/jbc.271.42.25999","volume":"271","author":"JM Woodcock","year":"1996","unstructured":"Woodcock JM, Bagley CJ, Zacharakis B, Lopez AF . A single tyrosine residue in the membrane-proximal domain of the granulocyte-macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 receptor common beta-chain is necessary and sufficient for high affinity binding and signaling by all three ligands. J Biol Chem 1996; 271: 25999\u201326006.","journal-title":"J Biol Chem"},{"key":"BFleu2015348_CR2","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood.V88.9.3391.bloodjournal8893391","volume":"88","author":"U Testa","year":"1996","unstructured":"Testa U, Fossati C, Samoggia P, Masciulli R, Mariani G, Hassan HJ et al. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 1996; 88: 3391\u20133406.","journal-title":"Blood"},{"key":"BFleu2015348_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-2141.2000.02348.x","volume":"111","author":"S Militi","year":"2000","unstructured":"Militi S, Riccioni R, Parolini I, Sposi NM, Samoggia P, Pelosi E et al. Expression of interleukin 3 and granulocyte-macrophage colony-stimulating factor receptor common chain betac, betaIT in normal haematopoiesis: lineage specificity and proliferation-independent induction. Br J Haematol 2000; 111: 441\u2013451.","journal-title":"Br J Haematol"},{"key":"BFleu2015348_CR4","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","volume":"29","author":"KK Reichard","year":"2005","unstructured":"Reichard KK, Burks EJ, Foucar MK, Wilson CS, Viswanatha DS, Hozier JC et al. CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells. Am J Surg Pathol 2005; 29: 1274\u20131283.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2015348_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2050-7771-2-4","volume":"2","author":"U Testa","year":"2014","unstructured":"Testa U, Pelosi E, Frankel A . CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies. Biomark Res 2014; 2: 4.","journal-title":"Biomark Res"},{"key":"BFleu2015348_CR6","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.4049\/jimmunol.145.10.3432","volume":"145","author":"P Valent","year":"1990","unstructured":"Valent P, Besemer J, Sillaber C, Butterfield JH, Eher R, Majdic O et al. Failure to detect IL-3-binding sites on human mast cells. J Immunol 1990; 145: 3432\u20133437.","journal-title":"J Immunol"},{"key":"BFleu2015348_CR7","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/leu.2015.16","volume":"29","author":"A Pardanani","year":"2015","unstructured":"Pardanani A, Lasho T, Chen D, Kimlinger TK, Finke C, Zblewski D et al. Aberrant expression of CD123 (interleukin-3 receptor-alpha) on neoplastic mast cells. Leukemia 2015; 29: 1605\u20131608.","journal-title":"Leukemia"},{"key":"BFleu2015348_CR8","first-page":"54","volume-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","author":"HP Horny","year":"2008","unstructured":"Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L et al Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th edn. International Agency for Research and Cancer (IARC): Lyon, 2008; pp 54\u201363."},{"key":"BFleu2015348_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.leu.2403224","volume":"18","author":"U Testa","year":"2004","unstructured":"Testa U, Riccioni R, Diverio D, Rossini A, Lo Coco F, Peschle C . Interleukin-3 receptor in acute leukemia. Leukemia 2004; 18: 219\u2013226.","journal-title":"Leukemia"},{"key":"BFleu2015348_CR10","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood-2002-03-0852","volume":"100","author":"U Testa","year":"2002","unstructured":"Testa U, Riccioni R, Militi S, Coccia E, Stellacci E, Samoggia P et al. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 2002; 100: 2980\u20132988.","journal-title":"Blood"},{"key":"BFleu2015348_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1600-0609.2001.00320.x","volume":"66","author":"M De Waele","year":"2001","unstructured":"De Waele M, Renmans W, Vander Gucht K, Jochmans K, Schots R, Otten J et al. Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. Eur J Haematol 2001; 66: 178\u2013187.","journal-title":"Eur J Haematol"},{"key":"BFleu2015348_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2009.08.019","volume":"16","author":"D Chauhan","year":"2009","unstructured":"Chauhan D, Singh AV, Brahmandam M, Carrasco R, Bandi M, Hideshima T et al. Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target. Cancer Cell 2009; 16: 309\u2013323.","journal-title":"Cancer Cell"},{"key":"BFleu2015348_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1309\/UNM9TY9QJQNFFYTH","volume":"120","author":"YC Chen","year":"2003","unstructured":"Chen YC, Chou JM, Ketterling RP, Letendre L, Li CY . Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia. Am J Clin Pathol 2003; 120: 874\u2013881.","journal-title":"Am J Clin Pathol"},{"key":"BFleu2015348_CR14","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","volume":"28","author":"W Vermi","year":"2004","unstructured":"Vermi W, Facchetti F, Rosati S, Vergoni F, Rossi E, Festa S et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol 2004; 28: 585\u2013595.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2015348_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/leu.2015.11","volume":"29","author":"A Ray","year":"2015","unstructured":"Ray A, Das DS, Song Y, Richardson P, Munshi NC, Chauhan D et al. Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells. Leukemia 2015; 29: 1441\u20131444.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015348","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015348.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T06:10:29Z","timestamp":1692166229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFleu2015348"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.348","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,18]]},"assertion":[{"value":"22 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AP received a research grant from Stemline therapeutics for preclinical study of the CD123-targeting drug, SL-701. CB is an employee of Stemline Therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}